Jeffrey A Meckler Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey A Meckler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey A Meckler. Jeffrey A Meckler is a Director in QLT INC/BC ($QLTI) and a in Cocrystal Pharma, Inc. ($BZNE) and an CHIEF EXECUTIVE OFFICER in Cocrystal Pharma, Inc. ($BZNE) and a Director in Retrophin, Inc. ($RTRX) and an Chief Executive Officer in Intec Pharma Ltd. ($NTEC).
Address: C/O THE ANDRA GROUP, LLC 740 BROADWAY, 9TH FLOOR NEW YORK 10003 NY
Companies in which Jeffrey A Meckler is an Insider
Cocrystal Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey A Meckler: CHIEF EXECUTIVE OFFICER
Holdings: 657,161 shares
Latest Transaction: Mar 17 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intec Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey A Meckler: Chief Executive Officer
Holdings: 196,761 shares
Latest Transaction: Jul 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey A Meckler: Director
Holdings: 107,000 shares
Latest Transaction: Jun 21 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey A Meckler: Director
Holdings: 67,000 shares
Current Value: $1,344,690
Latest Transaction: May 18 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey A Meckler
Sentiment: All, COCP, NTEC, NVLN, RTRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 67,000 | 64 K to 67 K (+4.69 %) |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Option Exercise | A | 0.31 | 300,000 | 92,250 | 300,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 64,000 | 61 K to 64 K (+4.92 %) |
| Aug 29 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.68 | 20,000 | 13,620 | 196,761 | 176.8 K to 196.8 K (+11.31 %) |
| Aug 27 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.46 | 100,000 | 45,700 | 176,761 | 76.8 K to 176.8 K (+130.27 %) |